Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

Evaluation of N3-18F-FPrT, 18F-FLT and 18F-FMAU as PET probes in a tumor-bearing animal model

Chih-Yuan Lin, Chun-Yi Wu, Pei-Chia Chan, Ren-Shyan Liu, Mian Alauddin and Hsin-Ell Wang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 417;
Chih-Yuan Lin
1Institute of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun-Yi Wu
1Institute of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pei-Chia Chan
1Institute of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-Shyan Liu
2Department of Nuclear Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mian Alauddin
3Department of Experimental Diagnostic Imaging, MD Anderson Cancer Center, University of Texas, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsin-Ell Wang
1Institute of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

417

Objectives This study compared the effectiveness of three 18F-labeled thymidine analogues, N3-(3-18F-fluoropropyl)-thymidine (N3-18F-FPrT), 18F-FLT and 18F-FMAU, for the tumor detection with small animal PET in a NG4TL4 sarcoma-bearing mouse model.

Methods Starting from 3’,5’-Di-O-toluoyl-N3-(3-bromopropyl)-thymidine, N3-18F-FPrT was prepared in 1.5 h with acceptable radiochemical yield (30%, decay corrected) and high radiochemical purity (≧98%). 18F-FLT and 18F-FMAU were prepared according to the literature. Biological characterizations were performed to evaluate their potential for tumor detection.

Results The uptake of N3-18F-FPrT in NG4TL4 cell culture reached the plateau (cell-to-medium ratio, C/M, 2.71±0.027) after 10 min incubation, while that of 18F-FLT and 18F-FMAU kept increasing with time (C/M of 78.67±7.82 and 12.53±3.04 after 2 h incubation, respectively). Dynamic small animal PET imaging of tumor-bearing mice after administration of these three tracers all revealed rapid and significant tumor uptakes. Higher tumor-to-muscle ratios (T/M) derived from the images after administration of 18F-FLT (2.25±0.263 at 1 h p.i.) and 18F-FMAU (2.17±0.19 at 1 h p.i.) compared with that of N3-18F-FPrT (1.40±0.11 at 1 h p.i.) evidenced the more specific retention of these two tracers in tumor. The results of tracer biodistribution studies in tumor-bearing animals were consistent with those observed in imaging.

Conclusions 18F-FLT is demonstrated most promising (highest C/M ratio and T/M ratio) among these three PET probes for tumor detection by cellular uptake and animal studies, while N3-18F-FPrT only shows limited potential as a proliferation probe

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of N3-18F-FPrT, 18F-FLT and 18F-FMAU as PET probes in a tumor-bearing animal model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of N3-18F-FPrT, 18F-FLT and 18F-FMAU as PET probes in a tumor-bearing animal model
Chih-Yuan Lin, Chun-Yi Wu, Pei-Chia Chan, Ren-Shyan Liu, Mian Alauddin, Hsin-Ell Wang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 417;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of N3-18F-FPrT, 18F-FLT and 18F-FMAU as PET probes in a tumor-bearing animal model
Chih-Yuan Lin, Chun-Yi Wu, Pei-Chia Chan, Ren-Shyan Liu, Mian Alauddin, Hsin-Ell Wang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 417;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

  • In vivo evaluation of EGCG stabilized gold-198 nanoparticles in prostate cancer bearing mice
  • New Tc-carbonyl based octreotide derivatives
  • uPAR Targeted SPECT imaging probes for detection of breast cancer
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

New Radiopharmaceuticals-Oncology: Apoptosis, Angiogenesis & Proliferation

  • PET imaging of αvβ3 expression in tumors with 68Ga-labeled mono-, di- and tetrameric RGD peptides
  • Radiosynthesis and preliminary evaluation of [18F]DPA as a small-molecule apoptosis PET tracer
Show more New Radiopharmaceuticals-Oncology: Apoptosis, Angiogenesis & Proliferation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire